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Solid lipid nanoparticles (SLN) are considered as innovative drug carrier for topical 
application [1]. The small size of the lipid particles ensures close contact to the stratum 
corneum and can increase the amount of the drug penetrating into the skin and it allows 
controlled drug release [2].  
The aim of this study was to develop controlled release gels containing SLN dispersions 
loaded with Econazole Nitrate (ECN) and to evaluate ex vivo skin penetration of the drug 
released from the particles. 
The SLN dispersion compositions prepared by oil in water emulsification technique, using 
a rotor-stator homogeniser, is reported in Table 1. Precirol ATO® (PCR) as lipid carrier and 
Tween 80 as emulsifying agent were used.  







SLN 0 5.0 2.5 0 92.5 
SLN 1 5.0 2.5 1.0 91.5 
SLN 2 10.0 2.5 1.0 86.5 
Table 1: composition of SLN dispersions 
After preparation, SLN 1 and SLN 2 dispersions were added of a gelling agent (HPMC 
K100M 2.0% w/w) to yield gels (named SLN 1 gel and SLN 2 gel) containing a final 
concentration of 1.0% w/w ECN . A gel containing only ECN was prepared as reference 
formulation (ECN gel). 
SLN dispersions were characterized in terms of drug content and encapsulation efficiency. 
The particle size of SLN was determined before and after incorporation into gels. The 




Ex vivo drug penetration tests through the porcine stratum corneum were carried out using a 
modified USP Apparatus n. 1. 
The encapsulation efficiency for SLN 1 and SLN 2 range between 96%-102%. 
The SLN dispersions show a narrow particle size distribution; the mean diameter of 
nanoparticles was about 480 nm. For all formulations, the particle size remains constant 
over the period of 30 days.  























Figure 1: ex vivo ECN permeation from gels 
The amount of drug released after 2 h from gels is negligible. The release of ECN is higher 
and more irregular from the formulation without SLN (ECN gel) with respect to the gels 
containing SLN because of the controlled drug diffusion from the solid crystalline lipid. 
The ECN release rate from SLN gels depends on the total lipid concentration in 
nanoparticles. For SLN 1 gel containing 5% w/w of lipid, the release rate is about two fold 
higher than the SLN 2, containing 10% of Precirol; the higher lipid content leads to the 
formation of lipid-enriched shell SLN which determines slower release. 
These preliminary results suggest that SLN formulated in gels are promising controlled 
release dosage forms for the topical delivery of ECN. 
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